Literature DB >> 1472012

Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells.

C E Boumah1, D L Hogue, C E Cass.   

Abstract

We have examined binding of [3H]nitrobenzylthioinosine (NBMPR) and influx of [3H]thymidine in adherent cultures of human choriocarcinoma (BeWo) cells and, for comparison, cervical-carcinoma (HeLa) cells. Specific association of NBMPR with BeWo cells at 22 degrees C required 1.5 h to reach an equilibrium between free and bound ligand, whereas association with HeLa cells required 20-30 min. Scatchard analysis of NBMPR binding to low-density cultures of BeWo cells revealed a total of 27 x 10(6) sites per cell, consisting of two distinct populations that differed in their affinities for NBMPR. One population bound NBMPR with 'high' affinity (Bmax.1 15.0 pmol/10(6) cells; Kd1 0.6 nM) and the other, larger, population bound NBMPR with 'low' affinity (Bmax.2 29.0 pmol/10(6) cells; Kd2 14.5 nM). By contrast, HeLa cells possessed only 4.1 x 10(5) sites per cell, and these sites all bound NBMPR with the same affinity (Bmax. 0.7 pmol/10(6) cells; Kd 0.5 nM). Interaction of NBMPR with both populations of sites in BeWo cells could be blocked by nitrobenzylthioguanosine (NBTGR), dilazep or dipyridamole. Concentration-effect relationships for dilazep inhibition of binding of 1 nM- and 25 nM-NBMPR to BeWo cells were monophasic, with virtually complete inhibition achieved at 0.1 microM and 1 microM respectively. Plasma-membrane preparations from BeWo cells also had high numbers of NBMPR-binding sites, and u.v. irradiation of site-bound [3H]NBMPR in such preparations labelled polypeptides that migrated in electrophoretograms as a broad band with a peak M(r) of 60,000. The concentration-effect relationship for NBMPR inhibition of thymidine transport by BeWo cells was biphasic, with an IC50 for inhibition of the 'NBMPR-sensitive' component of 1.6 nM and a substantial (15-20%) component of flux that was not inhibited by 10 microM-NBMPR and was thus 'NBMPR-insensitive'. Vmax. values for thymidine transport by BeWo cells were 20-30-fold larger than the corresponding values for transport by HeLa cells. Elimination of the Na+ gradient had no effect on initial rates of thymidine fluxes measured in either the presence or the absence of NBMPR. Our results demonstrate that BeWo cells have an unusually large capacity for NBMPR-sensitive nucleoside transport, apparently resulting from high levels of expression of 'erythrocyte-like' transport elements, identified by their high-affinity interaction with NBMPR. The relationship of the low-affinity binding sites to NBMPR-sensitive transporter elements is uncertain.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1472012      PMCID: PMC1131985          DOI: 10.1042/bj2880987

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Inhibition of methotrexate-induced differentiation of cultured human choriocarcinoma (BeWo) cells by thymidine.

Authors:  N S Burres; C E Cass
Journal:  Cancer Res       Date:  1987-10-01       Impact factor: 12.701

3.  External location of sites on pig erythrocyte membranes that bind nitrobenzylthioinosine.

Authors:  F R Agbanyo; C E Cass; A R Paterson
Journal:  Mol Pharmacol       Date:  1988-03       Impact factor: 4.436

4.  Mediated transport of nucleosides in human erythrocytes. Specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membrane.

Authors:  C E Cass; L A Gaudette; A R Paterson
Journal:  Biochim Biophys Acta       Date:  1974-04-12

5.  Nucleoside transport in human and sheep erythrocytes. Evidence that nitrobenzylthioinosine binds specifically to functional nucleoside-transport sites.

Authors:  S M Jarvis; J D Young
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

6.  Iron metabolism in BeWo chorion carcinoma cells. Transferrin-mediated uptake and release of iron.

Authors:  A van der Ende; A du Maine; C F Simmons; A L Schwartz; G J Strous
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

7.  Identification of the erythrocyte nucleoside transporter as a band 4.5 polypeptide. Photoaffinity labeling studies using nitrobenzylthioinosine.

Authors:  J S Wu; F Y Kwong; S M Jarvis; J D Young
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

8.  Species differences in nucleoside transport. A study of uridine transport and nitrobenzylthioinosine binding by mammalian erythrocytes.

Authors:  S M Jarvis; J R Hammond; A R Paterson; A S Clanachan
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

9.  Identification of the nucleoside transporter in cultured mouse lymphoma cells. Photoaffinity labeling of plasma membrane-enriched fractions from nucleoside transport-competent (S49) and nucleoside transport-deficient (AE1) cells with [3H]nitrobenzylthioinosine.

Authors:  J D Young; S M Jarvis; J A Belt; W P Gati; A R Paterson
Journal:  J Biol Chem       Date:  1984-07-10       Impact factor: 5.157

10.  Uridine uptake by isolated intestinal epithelial cells of guinea pig.

Authors:  M Schwenk; E Hegazy; V Lopez del Pino
Journal:  Biochim Biophys Acta       Date:  1984-12-11
View more
  7 in total

1.  Functional production and reconstitution of the human equilibrative nucleoside transporter (hENT1) in Saccharomyces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q).

Authors:  M F Vickers; R S Mani; M Sundaram; D L Hogue; J D Young; S A Baldwin; C E Cass
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

2.  Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells.

Authors:  X Fang; F E Parkinson; D A Mowles; J D Young; C E Cass
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

3.  Functional expression of the nitrobenzylthioinosine-sensitive nucleoside transporter of human choriocarcinoma (BeWo) cells in isolated oocytes of Xenopus laevis.

Authors:  C E Boumah; C M Harvey; A R Paterson; S A Baldwin; J D Young; C E Cass
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

4.  Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells.

Authors:  Richard G E Archer; Václav Pitelka; James R Hammond
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

5.  Immunolocalisation of nucleoside transporters in human placental trophoblast and endothelial cells: evidence for multiple transporter isoforms.

Authors:  L F Barros; D L Yudilevich; S M Jarvis; N Beaumont; J D Young; S A Baldwin
Journal:  Pflugers Arch       Date:  1995-01       Impact factor: 3.657

6.  The adenosine transporter, ENT1, in cardiomyocytes is sensitive to inhibition by ethanol in a kinase-dependent manner: implications for ethanol-dependent cardioprotection and nucleoside analog drug cytotoxicity.

Authors:  Azza Ramadan; Zlatina Naydenova; Katarina Stevanovic; Jennifer B Rose; Imogen R Coe
Journal:  Purinergic Signal       Date:  2013-10-27       Impact factor: 3.765

7.  N-linked glycosylation of N48 is required for equilibrative nucleoside transporter 1 (ENT1) function.

Authors:  Alex Bicket; Imogen R Coe
Journal:  Biosci Rep       Date:  2016-08-31       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.